SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-070333
Filing Date
2024-03-19
Accepted
2024-03-18 18:34:02
Documents
15
Period of Report
2024-03-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d784366d8k.htm   iXBRL 8-K 37323
2 EX-99.1 d784366dex991.htm EX-99.1 14195
  Complete submission text file 0001193125-24-070333.txt   212300

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elym-20240314.xsd EX-101.SCH 3548
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elym-20240314_def.xml EX-101.DEF 13170
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elym-20240314_lab.xml EX-101.LAB 21809
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elym-20240314_pre.xml EX-101.PRE 14101
18 EXTRACTED XBRL INSTANCE DOCUMENT d784366d8k_htm.xml XML 4868
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 24760518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)